PCCTC
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology
Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology
Travis Gerke
Jake Vinson + The Prostate Cancer Clinical Trials Consortium
Leading Prostate Cancer Research Organization Partners with Florence - Florence
Prostate Cancer Clinical Trial Consortium (PCCTC) | Florence - Florence
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News
A collaboration between:
All Archives - EXINI Diagnostics AB
Movember - Networks
PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu
ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Prostate Cancer Clinical Trials Consortium | Memorial Sloan Kettering Cancer Center
The Prostate Cancer Clinical Trials Consortium (PCCTC) | LinkedIn
The Prostate Cancer Clinical Trials Consortium (PCCTC) | LinkedIn
PCCTC
COMPPARE Study Highlighted in Cancer Connections Presentation » COMPPARE
The PCCTC (@ThePCCTC) / Twitter
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study | Request PDF
The Prostate Cancer Clinical Trials Consortium (PCCTC) | LinkedIn
